ColetteNgoziOwensMD

Hematologic Oncology

Assistant Attending at Memorial Sloan Kettering Cancer Center

Overview of Dr. Owens

Dr. Colette Owens is an oncologist in Middletown, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Hackensack Meridian Health Riverview Medical Center, and Memorial Sloan Kettering Monmouth. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 7 years. She is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 45 doctors at Hackensack Meridian Health Riverview Medical Center who specialize in Oncology. She has more than 20 publications and over 500 citings.

Office
480 Red Hill Road
Middletown, NJ 07748
Book by Phone+1(360) 523-7103

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2010 - 2013
Rutgers Robert Wood Johnson Medical SchoolClass of 2010

Certifications & Licensure

FL State Medical License 2022 - Present
NJ State Medical License 2016 - 2025
NY State Medical License 2012 - 2025

Publications & Presentations

PubMed

Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94].
Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, Maria I Carlo, Andrea Knezevic
European Urology. 2025-01-01
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.
Pallawi Torka, Tatyana Feldman, Kerry J Savage, Nivetha Ganesan, Esther Drill
Journal of Clinical Oncology. 2024-12-11
Zanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation.
Anita Kumar, Jacob D Soumerai, Jeremy S Abramson, Jeffrey A Barnes, Philip C Caron
Blood. 2024-10-22

Abstracts/Posters

Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Colette Owens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...
Colette Owens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of ...
Colette Owens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Challenges of Managing Older Patients with Diffuse Large B-cell LymphomaSeptember 10th, 2018